Appropriate Patients for Olaratumab + Doxorubicin

Appropriate Patients for Olaratumab + Doxorubicin

ANNOUNCE: Combination of olaratumab and doxorubicin versus doxorubicin alone in patients with ad...Подробнее

ANNOUNCE: Combination of olaratumab and doxorubicin versus doxorubicin alone in patients with ad...

Olaratumab + Doxorubicin for Metastatic Soft-Tissue SarcomaПодробнее

Olaratumab + Doxorubicin for Metastatic Soft-Tissue Sarcoma

CTOS Rome STS Lecture 2 Phase 1B Study of Olaratumab plus Doxorubicin and Ifosfamide in Patients wПодробнее

CTOS Rome STS Lecture 2 Phase 1B Study of Olaratumab plus Doxorubicin and Ifosfamide in Patients w

Dr. Robin Jones on Olaratumab and Doxorubicin in Patients with Soft Tissue SarcomaПодробнее

Dr. Robin Jones on Olaratumab and Doxorubicin in Patients with Soft Tissue Sarcoma

Toxicity of Olaratumab and DoxorubicinПодробнее

Toxicity of Olaratumab and Doxorubicin